Genic Co., Ltd. (KOSDAQ: 123330)

Market Cap	126.76B
Revenue (ttm)	28.94B
Net Income (ttm)	-2.37B
Shares Out	7.82M
EPS (ttm)	-345.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,701,008
Open	10,820
Previous Close	10,720
Day's Range	10,820 - 13,930
52-Week Range	2,880 - 13,930
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About Genic

Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands. Genic Co., Ltd. was founded in 2001 and ...

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2001
• Employees: 189
• Stock Exchange: KOSDAQ
• Ticker Symbol: 123330

Financial Performance

In 2023, Genic's revenue was 28.07 billion, a decrease of -10.74% compared to the previous year's 31.45 billion. Losses were -4.41 billion, 32.1% more than in 2022.